Corvert

This page contains recent news articles, when available, and an overview of Corvert but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Strip mall blaze causes $8M damage  -  ‎Oct 23, 2009‎
...(Chris Kitching/SUN MEDIA) A corvert sits surroundedd by water after a strip mall fire that began on Oct. 22, 2009. Damage is estimated at $8 million. ... Winnipeg Sun

Press Release: ProRhythm Initiates US Pivotal Trial for HIFU Ablation...  -  Jan 11, 2007
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Cardiome Announces Positive Phase 2a Results For Oral ...  -  Sep 13, 2006
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: CryoCath Announces Fiscal 2005 Third Quarter Results. ...  -  Aug 11, 2005
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: MedicalCV Announces Continued Milestone …  -  Jan 5, 2005
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Cardiome Announces Positive Phase 2b Results For Oral ...  -  Jul 14, 2008
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Press Release: Cardiome Completes ACT 3 Enrolment. - PR Newswire | …  -  Jul 21, 2005
...a common heart condition that ... percent of 50 patients suffering from atrial fibrillation who received CORVERT(R) (ibutilide ... of CORVERT. ... Pay-Per-View - PR Newswire - HighBeam Research

Cardiome Falls After US Doesn't Approve Heart Drug  -  Aug 11, 2008
Pfizer Inc.'s Corvert infusion, approved in 1995, and Tikosyn capsule, approved in 1999, are the only FDA-approved medicines to correct atrial fibrillation, ... Bloomberg

Cardiome, Astellas Heart Drug Wins US Panel's Vote  -  Dec 11, 2007
Pfizer Inc.'s Corvert infusion, approved in 1995, and Tikosyn capsule, approved in 1999, are the only FDA-endorsed medicines to correct atrial fibrillation, ... Bloomberg

Article: Heart of the Matter Doctors attack leading cause of stroke -...  -  May 1, 2006
...can increase the ... administration of CORVERT. Irregular Heart Beat Atrial fibrillation is a rapid, irregular heart rhythm originating in the atria ... ... Pay-Per-View - The Gazette - HighBeam Research

Article: Doctors attack leading cause of stroke. - Gazette (Colorado ...  -  May 5, 2006
...can increase the ... administration of CORVERT. Irregular Heart Beat Atrial fibrillation is a rapid, irregular heart rhythm originating in the atria ... ... Pay-Per-View - The Gazette - HighBeam Research

George Kilpatrick, retired plant supervisor -  -  Nov 19, 2005
Lawrence of Buffalo; a sister, Annie Mae Parnell of Meridian; a brother, Clifton of Corvert, Mich.; three grandchildren; and six great-grandchildren. $2.95 - Buffalo News - NewsBank

Joint guideline released for atrial fibrillation.(Practice Guidelines)...  -  May 15, 2007
...for pharmacologic cardio-version of atrial fibrillation are flecainide (Tambocor), dofetilide (Tikosyn), propafenone (Rythmol), and ibutilide (Corvert). ... Free with registration - American Family Physician - AccessMyLibrary.com

Kos Announces Introduction of Niaspan In Canada  -  Apr 26, 2005
Oryx currently promotes several prescription pharmaceutical products in Canada including two cardiovascular therapies, Corvert(R), from Pfizer Canada, ... RedOrbit

Press Release: Symmetrix Pharmaceuticals Announces the Appointment …  -  Dec 23, 2008
...the Class III anti-arrhythmic agent, Corvert(R). He also led cardiovascular drug discovery teams identifying novel thrombolytics, Factor Xa inhibitors, ... Pay-Per-View - PR Newswire - HighBeam Research

New AF guidelines place emphasis on stroke risk.(RX CARE)(Atrial …  -  Nov 6, 2006
Treatment with flecainide, dofetilide (Tikosyn, Pfizer), propafenone, or ibutilide (Corvert, Pfizer) is recommended for pharmacological cardioversion of AF. ... $4.95 - Drug Topics - ECNext

Joint guideline released for atrial fibrillation.(Practice Guidelines)...  -  May 15, 2007
...for pharmacologic cardio-version of atrial fibrillation are flecainide (Tambocor), dofetilide (Tikosyn), propafenone (Rythmol), and ibutilide (Corvert). ... $4.95 - American Family Physician - ECNext

Washington Administrative Code - WAC 260-70-680 This section …  -  Mar 17, 2006
Wytensin Heptaminol Corofundol Homatropine Homapin Hydralazine Apresoline 4-Hydroxytestosterone Ibutilide Corvert Iloprost Ventavis Indomethacin Indocin ... Pay-Per-View - Washington Administrative Code - Loislaw

Article: Patients with heart irregularities have several treatment...  -  Jul 25, 2005
...can increase the ... administration of CORVERT. Irregular Heart Beat Atrial fibrillation is a rapid, irregular heart rhythm originating in the atria ... ... Pay-Per-View - Daily Herald - HighBeam Research

Article: Replacing Heart Device Could Be Risky - AP Online | HighBeam...  -  Apr 25, 2006
Article: CORVERT(R) Injection (ibutilide fumarate injection) Restores ... PR Newswire; August 9, 1999 ; 700+ words ... ... treatment for patients suffering ... Pay-Per-View - AP Online - HighBeam Research

Press Release: Cardiome reports additional ACT 1 clinical results; …  -  Feb 4, 2005
Article: CORVERT(R) Injection (ibutilide fumarate injection) Restores ... PR Newswire; August 9, 1999 ; 700+ words ... ... successfully restored to a normal ... Pay-Per-View - PR Newswire - HighBeam Research

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.